Daniel Cox

1/ When starting a🤖Whipple program, struggle is always balancing patient selection for safe completion vs⬇️volume w being selective. We asked if it was safe w being liberal w pt selection w a lower threshold to convert for non-progression. Results in🧵! sciencedirect.com/science/articl…

With robust clinical evidence for #MachinePerfusion (MP) for #LiverTransplantation…it is here to stay. But how do transplant departments develop their machine perfusion services? Cost is a key factor 💰Our latest paper in @TransplantJrnl reviews the evidence for cost-effectiveness of MP. These data are critical to develop institutional and policy-level investment in MP technologies🏥@Murali_HPBSurg @austin_HRG @SoMeTransplant @TSANZ_txsoc journals.lww.com/transplantjour…

Excellent day at the @BTStransplant International Liver Transplant Oncology Symposium @ Kings. Lots to think about, 💎 from the frontline of this re-emerging field. And so good to catch up with a few friends! 🇬🇧🇦🇺 @DrGERidd @Murali_HPBSurg @GutFailure @OxTxResearch @austin_HRG

The dying specialty of “General Surgery”, as noted by authors from each and every decade over the last 100 years.

⁦@uhbtrust⁩ ⁦@Bham_HPB_LTx⁩ ⁦@BridgetoLifeLTD⁩ ⁦@NeilRajJ1⁩ ⁦@UHB_HPB⁩ 2nd UK National HOPE meeting. George Clark pc the evolution of machine perfusion in #livertransplant ⁦@uhbtrust⁩. Game changer with lack of DBD offers nationally

Great to have Dr Varuna Aluvihare coming from the world class Kings Liver unit to deliver a talk on post-LT IS in Birmingham. Food for thought, great review of data, & pleasure to hear his experiences. Thank you and here’s to more Birmingham-Kings sessions/cross-pollination

🆕Online today: Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable #pancreaticpancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial @BasGrootKoerkam, @MarcBesselink, Dutch Pancreatic Cancer Group thelancet.com/journals/lanon…

Energy transformation machinery inside mitochondria

MitoArt — may the bioenergetic boat/hypothesis of health and disease take us closer to the truth

We're saddened to hear of the passing of A/Prof Alexander Dobrovic @AlexDobrovic. A dedicated cancer researcher and epigeneticist, his lab was at the forefront of bringing epigenetic based tests into the clinic. 1/3

@GutFailure @bc_diet @UniMelb @Austin_Health Congratulations Brooke! ⭐️

Congratulations to @bc_diet on successfully completing her @UniMelb PhD - the first dietician to do so at @Austin_Health. A significant contribution to the nutritional management of patients with advanced chronic liver disease, highlighted by her pivotal RCT described 👇

Today Mass General Hospital has announced the world’s first successful transplant of a genetically-edited pig (porcine) kidney into a 62-year-old man living with end-stage kidney disease. Check out the article: massgeneral.org/news/press-rel…

Congratulations @COXdaniel on your exceptional PhD thesis. 👏🏽👏🏽 Very proud to be able to hold the printed volume , a work of scientific art. Glad to have been on this journey with you. The future is extremely bright. Thank you fellow supervisors @TGEG_ResDx and @GutFailure.

👍🏻🎄

Harnessing #cfDNA🧬to enhance precision in #livertransplant care..take a look at the next step in our research in @TransplantJrnl➡️analysing #mitochondria-derived cfDNA as a potential, objective tool to help evaluate graft viability for Tx during warm machine perfusion(@organ_ox)

'Hospital at home' could be the future of health care. Not everyone thinks it's a good idea ti.me/3FfNM0d

@Mielke_Lisa @ONJCRI @SciImmunology @MarinaYakou @Sonia_Ghi Congratulations all, fantastic work 🔥👍🏻

Thrilled to share the first research story from my lab @ONJCRI published in @SciImmunology. A real team effort from all lab members, in particular @MarinaYakou @Sonia_Ghi Kelly Tran & Dinesh Raghu science.org/doi/10.1126/sc…

@TXPDirect @GutFailure

This study among American intestinal transplant centers reveals the extreme heterogeneity of practices in immunosuppressive treatment. #OpenAccess #MedTwitter #TransplantTwitter bit.ly/44QKScE